Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milademetan in Advanced/Metastatic Solid Tumors (MANTRA-2)
NCT05012397Phase 2Terminated
- Sponsor
- Rain Oncology Inc.
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milademetan in solid tumor, sponsored by Rain Oncology Inc.. Started Nov 2021; status: terminated.
02
Drugs
milademetan
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05012397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05012397.